Randomised clinical trial: pregabalin attenuates experimental visceral pain through sub-cortical mechanisms in patients with painful chronic pancreatitis
- 16 August 2011
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 34 (8) , 878-887
Abstract
Pregabalin has a broad spectrum of analgesic and antihyperalgesic activity in both basic and clinical studies. However, its mechanisms and sites of action have yet to be determined in humans. To assess the antinociceptive effect of pregabalin on experimental gut pain in patients with visceral hyperalgesia due to chronic pancreatitis and to reveal putative changes in corresponding central pain processing as assessed by evoked brain potentials. Thirty-one patients were randomly assigned to receive increasing doses of pregabalin or placebo for three consecutive weeks. Perceptual thresholds to electrical stimulation of the sigmoid with recording of corresponding evoked brain potentials were obtained at baseline and study end. The brain source localisations reflecting direct neuronal activity were fitted by a five-dipole model projected to magnetic resonance imaging of the individuals' brains. As compared to placebo, pregabalin significantly increased the pain threshold to electrical gut stimulation from baseline (P=0.02). No differences in evoked brain potential characteristics were seen, neither after pregabalin nor placebo treatment (all P>0.05). In agreement with this, brain source locations remained stable during study treatment (all P>0.05). Pregabalin was superior to placebo for attenuation of experimental visceral pain in chronic pancreatitis patients. We suggest its antinociceptive effects to be mediated primarily through sub-cortical mechanisms.Keywords
This publication has 44 references indexed in Scilit:
- The evidence for pharmacological treatment of neuropathic painPain, 2010
- Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational studyBritish Journal of Clinical Pharmacology, 2010
- Assessing efficacy of non‐opioid analgesics in experimental pain models in healthy volunteers: an updated reviewBritish Journal of Clinical Pharmacology, 2009
- Assessing analgesic actions of opioids by experimental pain models in healthy volunteers – an updated reviewBritish Journal of Clinical Pharmacology, 2009
- Effects of pregabalin on visceral pain responses and colonic compliance in ratsBritish Journal of Pharmacology, 2008
- Pregabalin decreases visceral pain and prevents spinal neuronal activation in ratsGut, 2007
- Assessment of Experimental Pain From Skin, Muscle, and Esophagus in Patients With Chronic PancreatitisPancreas, 2007
- Effect of a second-generation α 2 δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndromeGut, 2007
- Differential effect of opioids in patients with chronic pancreatitis: An experimental pain studyScandinavian Journal of Gastroenterology, 2007
- The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium ChannelJournal of Biological Chemistry, 1996